Data Composite

Rifampin Injection Shortage

3 of 3 tracked records currently active across 3 manufacturers.

Manufacturers report shortage status per product/package to the FDA independently, so the same generic drug can be short from one company while another still has supply -- the table below breaks that down company by company.

CompanyBrand nameStatusLast updated
Mylan Institutional, a Viatris Company RIFAMPIN Current 09/03/2026
Fresenius Kabi USA, LLC RIFAMPIN Current 09/01/2026
Sanofi-Aventis U.S. LLC RIFADIN IV Current 06/22/2026

← All shortages